{"componentChunkName":"component---src-templates-news-news-template-tsx","path":"/news/biweekly-news-about-life-science-market-02022021","result":{"pageContext":{"article":{"id":152,"title":"Biweekly News about Life Science Market 02/02/2021","slug":"biweekly-news-about-life-science-market-02022021","article":"<p><span style=\"font-family: Arial, sans-serif;\"><a href=\"https://panoramafarmaceutico.com.br/2021/02/01/em-quatro-decadas-brasil-reduz-de-55-para-5-capacidade-de-producao-de-insumos-farmaceuticos/\" target=\"_blank\" style=\"color: blue; text-decoration: underline;\"></a></span></p><p><span style=\"font-family: Arial, sans-serif;\"><a href=\"https://panoramafarmaceutico.com.br/2021/02/01/em-quatro-decadas-brasil-reduz-de-55-para-5-capacidade-de-producao-de-insumos-farmaceuticos/\" target=\"_blank\" style=\"color: blue; text-decoration: underline;\"></a></span></p><p><span style=\"font-family: Arial, sans-serif;\"><a href=\"https://panoramafarmaceutico.com.br/2021/02/01/em-quatro-decadas-brasil-reduz-de-55-para-5-capacidade-de-producao-de-insumos-farmaceuticos/\" target=\"_blank\" style=\"color: blue; text-decoration: underline;\"></a></span></p><p><span style=\"font-family: Arial, sans-serif;\"><a href=\"https://panoramafarmaceutico.com.br/2021/02/01/em-quatro-decadas-brasil-reduz-de-55-para-5-capacidade-de-producao-de-insumos-farmaceuticos/\" target=\"_blank\" style=\"color: blue; text-decoration: underline;\"></a></span></p><h2 style=\"margin-right: 0px; margin-left: 0px; font-family: &quot;Times New Roman&quot;, serif; font-weight: bold; text-align: justify; font-size: 24px;\"><span style=\"font-family: Arial, sans-serif;\"><span style=\"font-family: Helvetica, sans-serif;\"><a href=\"https://panoramafarmaceutico.com.br/2021/02/01/em-quatro-decadas-brasil-reduz-de-55-para-5-capacidade-de-producao-de-insumos-farmaceuticos/\" target=\"_blank\">In four decades,                Brazil reduces from 55% to 5% production capacity of pharmaceutical inputs</a></span></span></h2><p style=\"margin-right: 0px; margin-left: 0px; font-family: &quot;Times New Roman&quot;, serif; text-align: justify; font-size: 16px;\"><span style=\"font-family: Arial, sans-serif;\"><span style=\"font-family: Helvetica, sans-serif;\"><a href=\"https://panoramafarmaceutico.com.br/2021/02/01/em-quatro-decadas-brasil-reduz-de-55-para-5-capacidade-de-producao-de-insumos-farmaceuticos/\" target=\"_blank\">In four decades,                Brazil reduces from 55% to 5% production capacity of pharmaceutical inputs  In the 1980s, Brazil                produced 55% of the pharmaceutical inputs consumed in the country. Today, this                percentage has dropped to 5%, according to data from Abiquifi (Brazilian                Association of the Pharmaceutical Inputindustry).</a></span></span></p><p style=\"text-align: justify;\">\n\n</p><p style=\"margin-right: 0px; margin-left: 0px; font-family: &quot;Times New Roman&quot;, serif; text-align: justify; font-size: 16px;\"><span style=\"font-family: Helvetica, sans-serif;\">&nbsp;</span></p><p style=\"text-align: justify;\">\n\n</p><h2 style=\"margin-right: 0px; margin-left: 0px; font-family: &quot;Times New Roman&quot;, serif; font-weight: bold; text-align: justify; font-size: 24px;\"><span style=\"font-family: Arial, sans-serif;\"><span style=\"font-family: Helvetica, sans-serif;\"><a href=\"https://panoramafarmaceutico.com.br/2021/02/02/balanca-comercial-do-setor-de-hppc-tem-superavit-de-us-23-4-milhoes-em-2020/\" target=\"_blank\">HPPC sector trade                balance has a surplus of US$ 23.4 million in 2020</a></span></span></h2><p style=\"margin-right: 0px; margin-left: 0px; font-family: &quot;Times New Roman&quot;, serif; text-align: justify; font-size: 16px;\"><span style=\"font-family: Arial, sans-serif;\"><span style=\"font-family: Helvetica, sans-serif;\"><a href=\"https://panoramafarmaceutico.com.br/2021/02/02/balanca-comercial-do-setor-de-hppc-tem-superavit-de-us-23-4-milhoes-em-2020/\" target=\"_blank\">HPPC sector trade                balance has a surplus of US$ 23.4 million in 2020  The trade balance of                the Brazilian sector of personal hygiene, perfumery and cosmetics recorded a                surplus of US$ 23.4 million in 2020, reversing the deficit value recorded in                2019, of US$ -105.9 million. The data were released by the Ministry of Economy.</a></span></span></p><p style=\"text-align: justify;\">\n\n</p><p style=\"margin-right: 0px; margin-left: 0px; font-family: &quot;Times New Roman&quot;, serif; text-align: justify; font-size: 16px;\"><span style=\"font-family: Helvetica, sans-serif;\">&nbsp;</span></p><p style=\"text-align: justify;\">\n</p><h2 style=\"margin-right: 0px; margin-left: 0px; font-family: &quot;Times New Roman&quot;, serif; font-weight: bold; text-align: justify; font-size: 24px;\"><span style=\"font-family: Arial, sans-serif;\"><span style=\"font-family: Helvetica, sans-serif;\"><a href=\"https://www.doisamaiscosmetica.com.br/mercado-negocios/natura-co-se-torna-a-maior-empresa-b-do-mundo/\" target=\"_blank\">Natura &amp; Co                becomes the world's largest B Company&nbsp;</a></span></span></h2><p style=\"margin-right: 0px; margin-left: 0px; font-family: &quot;Times New Roman&quot;, serif; text-align: justify; font-size: 16px;\"><span style=\"font-family: Arial, sans-serif;\"><span style=\"font-family: Helvetica, sans-serif;\"><a href=\"https://www.doisamaiscosmetica.com.br/mercado-negocios/natura-co-se-torna-a-maior-empresa-b-do-mundo/\" target=\"_blank\">Natura &amp; Co                becomes the world's largest B Company  B Companies meet the                highest standards of social and environmental performance verification, public                transparency and legal responsibility when reconciling profit and purpose.                Natura, The Body Shop and Aesop have already received the seal, while Avon                certification is scheduled for 2025.</a></span></span></p><p style=\"text-align: justify;\">\n\n</p><p style=\"margin-right: 0px; margin-left: 0px; font-family: &quot;Times New Roman&quot;, serif; text-align: justify; font-size: 16px;\"><span style=\"font-family: Helvetica, sans-serif;\">&nbsp;</span></p><p style=\"text-align: justify;\">\n\n</p><h2 style=\"margin-right: 0px; margin-left: 0px; font-family: &quot;Times New Roman&quot;, serif; font-weight: bold; text-align: justify; font-size: 24px;\"><span style=\"font-family: Arial, sans-serif;\"><span style=\"font-family: Helvetica, sans-serif;\"><a href=\"https://panoramafarmaceutico.com.br/2021/02/02/5-avancos-tecnologicos-que-transformarao-a-cadeia-de-suprimentos-do-setor-farmaceutico/\" target=\"_blank\">5 technological                advances that will transform the supply chain of the pharmaceutical sector&nbsp;</a></span></span></h2><p style=\"margin-right: 0px; margin-left: 0px; font-family: &quot;Times New Roman&quot;, serif; text-align: justify; font-size: 16px;\"><span style=\"font-family: Arial, sans-serif;\"><span style=\"font-family: Helvetica, sans-serif;\"><a href=\"https://panoramafarmaceutico.com.br/2021/02/02/5-avancos-tecnologicos-que-transformarao-a-cadeia-de-suprimentos-do-setor-farmaceutico/\" target=\"_blank\">5 technological                advances that will transform the supply chain of the pharmaceutical sector  The volume of                vaccines for covid-19, which are expected to be distributed in the near future,                will be unprecedented. Supply chains in the pharmaceutical sector will be                widely expanded so that such products can reach their destination quickly and                safely.</a></span></span></p><p style=\"text-align: justify;\">\n\n</p><p style=\"margin-right: 0px; margin-left: 0px; font-family: &quot;Times New Roman&quot;, serif; text-align: justify; font-size: 16px;\"><span style=\"font-family: Helvetica, sans-serif;\">&nbsp;</span></p><p style=\"text-align: justify;\">\n\n</p><p style=\"text-align: justify;\">\n\n</p><p style=\"margin-right: 0px; margin-left: 0px; font-family: &quot;Times New Roman&quot;, serif; text-align: justify; font-size: 16px;\"><span style=\"font-family: Arial, sans-serif;\"><span style=\"font-family: Helvetica, sans-serif;\"><a href=\"https://conteudo.kivalitaconsulting.com/newsletter\" target=\"_blank\" style=\"\"><strong>Sign up for our Fortnightly newsletter and                be the first to know!</strong></a></span></span></p>","published":true,"createdAt":"2021-02-02T12:59:07.6369502","imageId":297,"postImage":{"id":297,"type":"Blog","fileName":"047594f1-d0aa-4a5a-8f9d-8f7a6577a6cb.jpg","imageData":null,"imageUrl":"https://kivalitaapi.azurewebsites.net/resources/images/047594f1-d0aa-4a5a-8f9d-8f7a6577a6cb.jpg","url":null,"imageString":null},"authorId":13,"imageData":null,"language":0,"isNews":true,"isLegislation":false,"linkId":151,"translateSlug":"noticias-quinzenais-do-setor-de-life-science-020221"}}},"staticQueryHashes":["4202924991"]}